Evaluation of the oral human abuse potential of Oxycodone DETERx® formulation (Xtampza® ER)
Author(s) -
Diana Meske,
Ernest A. Kopecky,
Steven D. Passik,
Megan J. Shram
Publication year - 2018
Publication title -
journal of opioid management
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.331
H-Index - 39
eISSN - 2375-0146
pISSN - 1551-7489
DOI - 10.5055/jom.2018.0468
Subject(s) - oxycodone , medicine , placebo , crossover study , pharmacodynamics , pharmacokinetics , bioequivalence , oxymorphone , anesthesia , pharmacology , opioid , alternative medicine , receptor , pathology
To further characterize the human abuse potential and pharmacokinetics (PK) of Oxycodone DETERx (Xtampza® ER) after intact and chewed oral administration.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom